Fortis’s Agilus challenge deepens
Forced to buy out investors of its struggling diagnostics arm, Fortis now has the additional burden of reviving Agilus even as it’s trying to get the core healthcare business back on track.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
More in Business
You may also like
Bhavish Aggarwal’s latest desperate gamble with Ola cabs
Ola Consumer is gearing up for an IPO, but poor numbers, lack of direction and an uncertain path to profitability make the company a particularly risky bet for investors.
Valuation concerns and strategic missteps hinder Ambani’s Jio outcome
Ahead of its IPO, the mobile telephony leader is down to playing catch-up with Airtel. What should investors expect?
If we decide to list in the future, it will be based on a clear purpose: Manipal’s Dilip Jose
With talks of a possible blockbuster IPO doing the rounds, the CEO gets candid about how India’s top hospital chain is planning the future.
